You are here: Industry Insights > hepatitis C

News List

NHS plans to be first to eliminate hepatitis C pharmatimes
February 01, 2018
NHS England has laid out plans for England to become the first country to eliminate hepatitis C, at least five years earlier than the World Health Organisation’s target date of 2030.
CCMD offers inexpensive treatment for Hepatitis C biospectrumasia
January 03, 2018
Hepatitis C is known as a silent epidemic and it has been reported that 2,000 new cases emerging every year in Malaysia
As Merck cans another hepatitis C project, can leader Gilead capitalize? fiercepharma
September 30, 2017
These days, hep C isn’t looking like the cash cow market it once was, prompting some of those trailing behind leader Gilead to bail on their development programs.
FDA approves AbbVie’s Mavyret for hepatitis C europeanpharmaceuticalreview
August 07, 2017
The FDA has approved Mavyret to treat adults with chronic hepatitis C virus genotypes 1-6 without cirrhosis or with mild cirrhosis…
New hepatitis C therapies approved in Europe pharmatimes
August 01, 2017
Patients with hepatitis C in Europe could soon gain access to two new pan-genotypic treatment options after the European Commission issued approval for AbbVie’s Maviret and Gilead’s Vosevi following an accelerated review.
FDA approves Vosevi for Hepatitis C worldpharmanews
July 20, 2017
The U.S. Food and Drug Administration has approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.
Costs for generic hepatitis C drugs in India paid back in 5 years europeanpharmaceuticalreview
June 08, 2017
Use of the generic versions of directly-acting antiviral (DAA) drugs that are available in India to treat hepatitis C virus (HCV) infection is not only cost effective...
DRL launches Hepatitis C drug in India financialexpress
May 16, 2017
DRL’s Resof Total tablets are available in bottle count size of 28
New Hepatitis C Infections Hit 15-Year High: CDC drugs.com
May 15, 2017
Reports of new hepatitis C infections in the United States nearly tripled over five years, reaching a 15-year high, federal government data show.
New Hepatitis C Drugs Might Eliminate the Disease drugs.com
March 21, 2017
Newer treatments for hepatitis C appear to eliminate the virus in the vast majority of those taking oral antiviral medications, raising the hope that this disease might someday be eradicated in the United States.

Previous page 1 2 3 Next page